INS and Hepatic steatosis: Supplementation with n-3 PUFAs inhibited lipogenesis, attenuated hepatic oxidative stress, decreased inflammation and increased insulin sensitivity, further to preserve hepatic architecture and prevent hepatic steatosis (39).